10x Genomics, Inc. TXG Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s operating income?
- 10x Genomics, Inc. (TXG) reported operating income of -$17.05M in Q1 2026.
- How has 10x Genomics, Inc.'s operating income changed year-over-year?
- 10x Genomics, Inc.'s operating income increased by 56.7% year-over-year, from -$39.33M to -$17.05M.
- What is the long-term trend for 10x Genomics, Inc.'s operating income?
- Over 4 years (2021 to 2025), 10x Genomics, Inc.'s operating income has grown at a 3.9% compound annual growth rate (CAGR), from -$52.25M to -$60.99M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.